Pure Global AI
NCT06318234Recruiting

PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer

Research Focused on Developing and Assessing a Non-intrusive Diagnostic Approach for Grading Tumor Regression Post-neoadjuvant Treatment in Rectal Cancer, Utilizing 18F-FAPI in Conjunction With FDG PET/MR Imaging.
Xiao ChenClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Rectal Cancer
Drug/Device/Intervention
18F-FAPI，18F-FDG
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Xiao Chen
Funder
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Location
Chongqing, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Dec 31, 2025
Enrollment
32 participants
Primary outcome

Evaluation efficacy of tumor regression level

Summary

This project aims to evaluate the role of 18F-FAPI combined with 18F-FDG PET/MRI imaging in
 quantitatively and accurately evaluating the grading of rectal cancer after SCRT neoadjuvant
 therapy in patients with advanced rectal cancer as the research object, with postoperative
 histopathological analysis as the reference index, and to assess the ability of patients to
 achieve pCR. A diagnostic model and evaluation system will also be constructed.

ICD-10 classifications
Malignant neoplasm of rectumCarcinoma in situ: RectumBenign neoplasm: RectumSecondary malignant neoplasm of large intestine and rectumCarcinoma in situ: Rectosigmoid junction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06318234
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06318234 through Pure Global AI's free database. This phase not specified trial is sponsored by Xiao Chen and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 32 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.